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Triclosan (TCS) is an antimicrobial agent that was effectively banned by the FDA from hand
soaps in 2016, hospital soaps in 2017, and hand sanitizers in 2019; however, TCS can still be
found in a few products. At consumer-relevant, non-cytotoxic doses, TCS inhibits the functions
of mitochondria and mast cells, a ubiquitous cell type. Via the store-operated Ca2+ entry
mechanism utilized by many immune cells, mast cells undergo antigen-stimulated Ca2+ influx
into the cytosol, for proper function. Previous work showed that TCS inhibits Ca2+ dynamics in
mast cells, and here we show that TCS also inhibits Ca2+ mobilization in human Jurkat T cells.
However, the biochemical mechanism behind the Ca2+ dampening has yet to be elucidated.
Three-dimensional super-resolution microscopy reveals that TCS induces mitochondrial
swelling, in line with and extending the previous finding of TCS inhibition of mitochondrial
membrane potential via its proton ionophoric activity. Inhibition of plasma membrane potential
(PMP) by the canonical depolarizer gramicidin can inhibit mast cell function. However, use of
the genetically encoded voltage indicators (GEVIs) ArcLight (pH-sensitive) and ASAP2 (pH-

insensitive), indicates that TCS does not disrupt PMP. In conjunction with data from a plasma
membrane-localized, pH-sensitive reporter, these results indicate that TCS, instead, induces
cytosolic acidification in mast cells and T cells. Acidification of the cytosol likely inhibits Ca2+
influx by uncoupling the STIM1/ORAI1 interaction that is required for opening of plasma
membrane Ca2+ channels. These results provide a mechanistic explanation of TCS disruption of
Ca2+ influx and, thus, of immune cell function.
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CHAPTER 1
INTRODUCTION
Triclosan (TCS) is a formerly widespread antimicrobial agent: it was estimated that 75%
of the US population in 2008 was exposed to TCS (Calafat et al., 2008). Recently, the U.S. Food
and Drug Administration effectively banned TCS from hand soaps in 2016 (Kux, 2016b), from
hospital products in 2017 (Kux, 2017), and from over-the-counter hand sanitizers in 2019
(Gottlieb, 2019). TCS was also removed by the Colgate-Palmolive company from its top-selling
toothpaste product (Kary, 2019) in 2019. Despite these stoppages, TCS remains in some
antibacterial household products that are not regulated by the FDA and in a few remaining
personal care products (www.ewg.org). TCS is readily absorbed into the skin (Queckenberg et
al., 2010) and oral mucosa (Gilbert, 1987) where it remains for a significant time prior to
metabolism and clearance (Moss et al., 2000), thus allowing for a constant chronic exposure
upon periodic re-exposure. In this study, non-cytotoxic, micromolar TCS doses, that model
human exposure levels to TCS following personal care product application (Weatherly and
Gosse, 2017; Weatherly et al., 2018), are utilized. Added to consumer products for its
antimicrobial properties, TCS, ironically, inhibits the functioning of mammalian immune cells
whose physiological purpose is to fight microbial infections (Udoji et al., 2010; Palmer et al.,
2012; Hurd-Brown et al., 2013).
Clinically, TCS is used for its antimicrobial (Daoud et al., 2014) and anti-gingival
properties (Rover and Leu-Wai-See, 2014). Additionally, previous studies provided evidence
that TCS could potentially be used to treat atopic dermatitis (Sporik and Kemp, 1997; Tan et al.,
2010).

Despite these positive clinical effects, within the past few years a panoply of triclosan
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epidemiology studies have emerged, reporting various adverse TCS health effects (Weatherly
and Gosse, 2017). Adverse TCS-linked effects on the reproductive system include increased
spontaneous abortion rate (Wang et al., 2015), abnormal sperm morphology (Jurewicz et al.,
2018; Zamkowska et al., 2018), and decreased fecundity (Vélez et al., 2015; Zhu et al., 2019).
Additionally, newborn infants’ weight, length, and head circumference decreased due to TCS
exposure (Etzel et al., 2017). Cognitive effects have also been observed; TCS has been linked to
lower cognitive test scores in children (Jackson-Browne et al., 2018) and to higher behavior
problem scores in 8-year old boys (Jackson-Browne et al., 2019). TCS causes metabolic effects
including decreased BMI (Li et al., 2015), increased risk of gestational diabetes (Ouyang et al.,
2018), changes in thyroid hormone levels in blood (Koeppe et al., 2013; Wang et al., 2017) and
increased risk of type 2 diabetes in women (Xie et al., 2020). Triclosan exposure is also
associated with decreased bone mass density and increased osteoporosis (Cai et al., 2019).
Additionally, allergic rhinitis has been associated with TCS exposure (Kim and Kim, 2019).
However, the cellular and molecular mechanisms underlying these epidemiological observations
are not fully understood. Triclosan inhibition of mast cells (Palmer et al., 2012; Weatherly et al.,
2013) and mitochondria (Ajao et al., 2015; Shim et al., 2016; Weatherly et al., 2016; Weatherly
et al., 2018; Weatherly et al., 2020), in human cells (Weatherly et al., 2016) and in other species,
may be related to these human health effects.
One of the underlying mechanisms of adverse human health effects caused by TCS may
be its mitochondrial toxicity. An uncoupler due to its ionizable proton (Ajao et al., 2015;
Weatherly et al., 2016), triclosan inhibits adenosine triphosphate (ATP) production and increases
oxygen consumption rate in multiple cell types (Weatherly et al., 2016) and in live zebrafish
(Shim et al., 2016). Additionally, TCS deflates mitochondrial membrane potential (MMP),

2

thwarts mitochondrial translocation and Ca2+ dynamics, and induces mitochondrial fission and
deformation (as assessed in two-dimensional [2D], super-resolution, live-cell microscopy
(Weatherly et al., 2018). Mitochondria play a role in cytosolic and ER Ca2+ uptake that supports
Ca2+ homeostasis in cells, which are important mechanisms needed in maintaining mast cell
functions (Takekawa et al., 2012; Furuno et al., 2015). These TCS effects on MMP and
mitochondrial morphology have been recapitulated in an in vivo mouse study (Weatherly et al.,
2020). Critically, mitochondrial toxicity by TCS has been directly connected to its instigation of
inflammation and immunotoxicity: TCS increases Drp1 and decreases Opa1 expression levels,
effects which both increase mitochondrial fission and activate the NLRP3 inflammasome
(Weatherly et al., 2020).
Separate from its mitochondrial toxicity, TCS disrupts other cellular signal transduction
processes, such as Ca2+ mobilization and cytoskeletal remodeling, which are shared by numerous
cell types (Weatherly et al., 2018). For example, TCS disrupts the functioning of the
immunological/neurological cell type mast cells; TCS mitotoxicity does not explain this
inhibition (Weatherly et al., 2018). Mast cells are found in a large variety of tissues (Dvorak,
1986; Theoharides and Sant, 1991; Farrell et al., 1995; Blank et al., 2007) and are involved in
defense against parasites (Metcalfe et al., 1997), bacteria (Johnzon et al., 2016), and cancer
(Hempel et al., 2017). Mast cell dysfunction is associated with neurological diseases (Silver and
Curley, 2013; Girolamo et al., 2017) such as multiple sclerosis (Elieh-Ali-Komi and Cao, 2017).
Of course, mast cells are also major effector cells of allergy and asthma (Galli et al., 2005), and
previous clinical reports of atopic disorder alleviation by TCS, noted above (Sporik and Kemp,
1997; Tan et al., 2010), align with our findings of mast cell inhibition by TCS (Palmer et al.,
2012).
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Mast cells undergo degranulation, the release of bioactive mediators such as histamine
and serotonin, in a process that begins with multivalent antigen (Ag) mediated cross-linking of
immunoglobulin E (IgE)-primed FcεRI receptors on the cell surface. This binding initiates a
phosphorylation cascade in which phospholipase C gamma (PLCγ) is activated (Kinet, 1999).
PLCγ subsequently cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) into diacylglycerol
(DAG) and inositol 1,4,5-trisphosphate (IP3). The latter is then able to bind to its receptor on the
endoplasmic reticulum (ER) membrane and initiate the release of ER Ca2+ stores into the cytosol
(Berridge, 1993). Reduced ER Ca2+ concentration results in altered conformation of ER protein
STIM1, causing it to bind to and change the conformation of the Orai1 subunit of the Ca2+
release-activated Ca2+ (CRAC) channel, opening it to a flood of external Ca2+ flowing into the
cytosol (Vig et al., 2006; Hogan et al., 2010); this process is termed store-operated Ca2+ entry, or
SOCE (Putney, 1986). SOCE is required for mast cell degranulation (as reviewed in (Holowka
et al., 2012) because increased cytosolic Ca2+ levels allow for events required for the movement
of granules to the plasma membrane for exocytosis, such as protein kinase C (PKC) activation
(Ozawa et al., 1993), phospholipase D (PLD) activation (Chahdi et al., 2002), and microtubule
polymerization (Guo et al., 1998; Smith et al., 2003).
These signaling processes are important in a variety of cell types, including in the
immune system and brain. SOCE mechanisms are largely conserved across cell types (Prakriya
and Lewis, 2015). For example, T-cell signaling (Marano et al., 1993; Trebak and Kinet, 2019)
also begins with T-cell receptor (TCR) cross-linking, as with FcεRI. In T-cells (part of the
adaptive immune system) in vivo, this crosslinking is primarily done by an antigen presenting
cell (APCs; innate immune cells such as macrophage or a dendritic cells), presenting antigen on
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the major histocompatibility complex (Punt et al., 2019). The TCR/APC interaction can be
emulated in vitro through the use of an anti-TCR antibody (Marano et al., 1993). Such crosslinking leads to PLCγ activation and subsequent generation of IP3 and SOCE, via the same
process outlined above for mast cells. The subsequent increase in cytosolic Ca2+ concentration
allows for calmodulin/calcineurin binding and subsequent activation of the nuclear factor of
activated T-cells (Punt et al., 2019; Trebak and Kinet, 2019), an important Ca2+-dependent
transcription factor. Thus, signaling upstream of SOCE is very similar between mast cells and Tcells; whereas signaling downstream of SOCE is largely different between mast cells and T-cells.
While TCS is known to interfere with bodily distribution of T cells (Anderson et al., 2016),
cytokine production (Barros et al., 2010; Marshall et al., 2015; Anderson et al., 2016; Marshall
et al., 2017), and expression of calcium-binding biomarkers of inflammation (Marshall et al.,
2017), triclosan effects on intracellular signal transduction, functional outcomes, and SOCE
within T cells have not yet been examined.
Triclosan disrupts mast cell function by strongly inhibiting Ag-stimulated Ca2+ influx
into the cytosol via the CRAC channels (Weatherly et al., 2018). This depressed cytosolic Ca2+
concentration leads, as expected, to inhibition of downstream events, such as reduced PLD
activity (Shim et al., 2019) and microtubule polymerization (Weatherly et al., 2018). Thus,
inhibition of SOCE by TCS explains its inhibition of mast cell function. The question remains:
how does TCS inhibit Ca2+ entry through CRAC channels?
One explanation could be TCS disruption of any of the upstream signaling events leading
to SOCE: FcεRI crosslinking, any link in the phosphorylation cascade, PIP2 signaling function,
or IP3 binding to its ER membrane receptor. However, TCS does not hinder Ca2+ efflux from the
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ER (Weatherly et al., 2018) and does not seriously interfere with PIP2 (Shim et al., 2019)—
evidence that TCS does not inhibit any of these events upstream of ER Ca2+ release.
Because TCS does not hamper the signaling events culminating in ER Ca2+ release, an
alternative mechanism underlies TCS inhibition of CRAC channel Ca2+ entry. Chemical
depolarization of plasma membrane potential (PMP) reduces Ca2+ entry into the cytosol of mast
cells (Mohr and Fewtrell, 1987a) and also of T cells (Sarkadi et al., 1990). Integrity of PMP is
important for SOCE due to its contribution to the free energy, ΔGtransport, available to import Ca2+
down its electrochemical gradient into the cytoplasm. In this study, we hypothesized that TCS,
as a proton ionophore (Weatherly et al., 2016), inhibits Ca2+ influx by depolarizing PMP
similarly to how TCS deflates membrane potential of mitochondria (Weatherly et al., 2018) and
of artificial bilayers (Popova et al., 2018)—by acting as a “Trojan horse” to provide safe passage
for protons through lipid membranes.
The driving force for Ca2+ influx through the CRAC channel is calculated as (Nelson and
Cox, 2017)
∆𝐺!"#$%&'"( = 𝑅𝑇𝑙𝑛 (

𝐶)
* + 𝑛𝑍Ϝ∆Ψ
𝐶*

Using physiological temperature of 310K, the gas and Faraday’s constants, the number of
charges on the transported ion (n=2), the sign of the charge of the transported ion (Z=+), resting
PMP ∆Ψ of -82.5 mV (Lindau and Fernandez, 1986; Wischmeyer et al., 1995), C1 =
extracellular Ca2+ concentration in the buffer (1.8 mM), and C2 = average cytosolic Ca2+
concentration in an Ag-stimulated mast cell (1 µM) (Millard et al., 1988; Chandra et al., 1994),
the driving force (Gibbs free energy) for Ca2+ influx through open CRAC channels is the highly
exergonic value -35 kJ/mol. If TCS were to completely depolarize the mast cell PMP, the term
𝑛𝑍Ϝ∆Ψ would collapse to zero, the driving force behind SOCE would be reduced ~45%, to -19
6

kJ/mol, and, hence, 45% less Ca2+ would flood into the cell. In fact, this PMP-knockoutpredicted ~45% reduction in integrated Ca2+ influx was observed in mast cells following 20 µM
TCS exposure (Weatherly et al., 2018).
Thus, in this study, the first aim was to measure TCS effects on PMP in mast cells. The
mast cell model rat basophilic leukemia, clone 2H3 (RBL), which are functionally similar to
mature human mast cells, rodent mucosal mast cells, and basophils (Fewtrell et al., 1979;
Metzger et al., 1982; Seldin et al., 1985; Metcalfe et al., 1997; Abramson and Pecht, 2007; Lee
et al., 2012), was used. RBL cells are effective for toxicological studies due to their ability to
respond to exogenous agents in a similar fashion as primary bone-marrow derived mast cells
(Zaitsu et al., 2007; Thrasher et al., 2013; Alsaleh et al., 2016).
Conventionally, PMP is measured through the use of patch clamping or of voltagesensitive fluorescent organic dyes. However, traditional patch clamping is a low-throughput
process. Also, TCS is a chemical quencher of many unprotected fluorescent chromophores (such
as those found in organic voltage sensitive dyes) (Weatherly, 2017). Thus, genetically encoded
voltage indicators (GEVIs), reporter protein constructs with a β-barrel protein structure that
protects the internal fluorophore from TCS fluorescence interference (Weatherly, 2017;
Weatherly et al., 2018) were used. Targeted to the plasma membrane, GEVIs communicate
changes in PMP through changes in fluorescence intensity. To our knowledge, this study
represents the first use of a GEVI in an immune cell model or in the field of toxicology.
An additional novel use of a biophysical technique in toxicology, three-dimensional (3D)
Fluorescence Photoactivation Localization Microscopy (FPALM) super-resolution microscopy
was also employed to detail TCS effects, via membrane depolarization, on mitochondrial
morphology in mast cells (Parent and Hess, 2019). Conventional light microscopy, including
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widefield and confocal imaging, cannot resolve objects that are less than ~250 nm apart, due to
the diffraction limit, but FPALM breaks this diffraction limit (Hess et al., 2006). These 3D
studies augment, by providing information on mitochondrial volume and surface area, previous
2D work showing that TCS disrupts mitochondrial nanostructure, causing “donut” shapes or
fragmentation (Weatherly et al., 2018).
In this study, we test the hypothesis that TCS inhibits mast cell function by depolarizing
the plasma membrane. However, careful experimentation with two GEVI constructs, which
function via disparate molecular machinery, indicate a wholly different mechanism of TCS
action: cytoplasmic acidification. Furthermore, TCS replicates this mechanism of action and
abrogation of function in another immune cell type, T cells.
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CHAPTER 2
METHODS
2.1 Chemicals and reagents
Triclosan (TCS; 99% purity; Sigma-Aldrich) was prepared in BT (Tyrodes buffer
containing bovine serum albumin [BSA]) without use of organic solvent (Weatherly et al., 2013)
and diluted to deliver non-cytotoxic concentrations (Palmer et al., 2012) checked by UV-Vis
spectrophotometry (Weatherly et al., 2013). Gramicidin (Sigma- Aldrich) was dissolved in
100% DMSO (Sigma-Aldrich) and diluted with BT.

2.2 Cell culture
RBL-2H3 mast cells were cultured as in (Hutchinson et al., 2011).
Human Jurkat T cells, clone E6-1, were obtained from ATCC and maintained in suspension
in phenol red-containing RPMI-1640 medium (ATCC) supplemented with 10% fetal bovine
serum (Atlanta Biologics) and 100 U/ml penicillin-100 µg/ml streptomycin (Sigma-Aldrich).
Cells were passaged once a week with thorough trituration technique to break up clumps, seeded
at 35,000 cells/mL (for 6-7 days until harvest) to 125,000 cells/mL (for 3 days), and grown at
37°C and 5% CO2. Supplement fresh media was added after 3 days in culture. These culturing
conditions resulted in maximal cell density of 1-2 million cells/mL.
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2.3 Fluorescence photoactivation localization microscopy (FPALM) imaging and
processing
Three-dimensional FPALM mitochondrial imaging was performed as in (Parent and
Hess, 2019). RBL cells were transfected with an expression vector for Dendra2-Tom20
(Weatherly et al., 2018) using an Amaxa transfection kit (Lonza), then plated in μ-Slide 8-well
plates with polymer coverslip (ibidi) at 100,000 cells/well in 200 µL/well phenol red-free RBL
media. The next day, cells were exposed to 20 µM TCS or BT for 1 hour and fixed with 4%
paraformaldehyde (Sigma Aldrich) before imaging. Imaging was performed using a 558 nm laser
(Crystalaser) for Dendra2-Tom20 excitation, and fluorescence was captured using an Olympus
IX-71 microscope with 60X 1.45NA oil lens, 2X telescope, and an EMCCD camera (Andor
iXon DU-897 #BV). Custom MATLAB analysis software was used to obtain localized data
points (Hess et al., 2006; Gudheti et al., 2013; Curthoys et al., 2019); details of microscopy are
in Appendix A.1 and A2.

2.4 FPALM mitochondrial analysis
In MATLAB, raw data was localized first by fitting each Point Spread Function (PSF) to
a two-dimensional (2D) Gaussian, which was then drift corrected. After drift correction,
following the methods in (Huang et al., 2008; Parent and Hess, 2019), the z-coordinate of each
localized point was obtained from the measured calibration curve connecting the x- and ywidths of the PSF as a function of z- position. After obtaining the z-position for each localized
point, the data set was processed through another custom MATLAB script for cluster
identification, which compares the distances between each localization and all nearby
localizations: localizations that lie within dmax (75 nm) of each other are considered to be in the
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same cluster. Clusters with a minimum number of 50 localizations were analyzed further. The
nearest-neighbor single linkage cluster analysis (SLCA) method (Sneath, 1957; Gudheti et al.,
2013) used here has been extended to three dimensions (Parent and Hess, 2019). Each cluster is
then analyzed using the MATLAB convex hull and alpha shape functions, in order to quantify
the local mean curvature for all localizations within an individual mitochondrion. Histograms
and averages of the curvature, area, and volume of the convex and alpha hulls are then
determined.

2.5 Degranulation assay
Degranulation assays were performed as in (Weatherly et al., 2013), adapted for use with
gramicidin in 0.003% DMSO vehicle.

2.6 DiSC3(5) fluorescence interference assay
Triclosan effects on DiSC3(5) (TCI America) organic voltage sensitive dye fluorescence
were assayed. The dye was dissolved in 100% DMSO. In a 96 well black bottom plate
(Greiner), DisC35 dye and TCS were mixed to achieve a final dye concentration of 1.02 μM in
0.01% final DMSO percentage, with various TCS concentrations (1-15 μM) in BT. The mixture
was allowed to equilibrate for 10 min at 37°C. Fluorescence measurements were taken using a
microplate reader (Synergy 2, Biotek) with 530 ± 20 nm excitation and 645 ± 15 nm emission.

2.7 Plasma membrane potential and cytosolic pH assays in RBL-2H3 mast cells
In order to measure changes in plasma membrane potential, RBL cells were transfected
with genetically-encoded voltage indicator (GEVI) protein construct ArcLight-A242 (a gift from
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Vincent Pieribone; Addgene plasmid # 36857; http://n2t.net/addgene:36857;
RRID:Addgene_36857) (Jin et al., 2012) or ASAP2 (pcDNA3.1/Puro-CAG-ASAP2s was a gift
from Francois St-Pierre; Addgene plasmid # 101274; http://n2t.net/addgene:101274;
RRID:Addgene_101274) (Chamberland et al., 2017). To investigate TCS effects on cytosolic
pH, RBL cells were transfected with plasma membrane-targeted Lyn-tailed mCherrySuperEcliptic (SE) pHluorin protein construct (Lyn-tailed mCherry-SEpHlourin was a gift from
Sergio Grinstein; Addgene plasmid # 32002; http://n2t.net/addgene:32002;
RRID:Addgene_32002) (Koivusalo et al., 2010). RBL cells were transiently transfected with
ArcLight A242, ASAP2, or Lyn-tailed mCherry-SuperEcliptic (SE) pHluorin through
electroporation using RBL-specific Amaxa Nucleofector transfection kit T (Lonza), then plated
in 8-well plates (ibidi) at ~150,000 cells/well in 200 µL/well phenol red-free RBL media. Cells
were grown for 16-24 hrs at 37oC/ 5% CO2. Before imaging, cells were washed with BT and the
media was replaced with 200 µL BT. After the initial, untreated, image was taken, cells were
treated with 200 µL of either BT (for control) or various 2X concentrations of TCS or
gramicidin, depending on the experiment. See “Confocal Microscopy” below for imaging
details.

2.8 Plasma membrane potential assay in Jurkat T cells
Ibidi 8-well plates were coated with 150 µL of human fibronectin (VWR) prepared at 166
µg/ml in phosphate buffered saline (PBS) (Lonza) (Wang et al., 2019) overnight in the tissue
culture incubator (37oC/ 5% CO2); these wells were washed the next day with 200 µL PBS/well
before use. Jurkat cells were transiently transfected with ArcLight-A242 through electroporation
using Jurkat-specific Amaxa Nucleofector transfection kit T (Lonza), then plated in the
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fibronectin pre-coated plates at ~1million cells/well in 300 µL phenol red-free Jurkat media.
Cells were grown for 16-24 hours at 37oC/ 5% CO2. Next day, cell media was removed carefully
with a transfer pipette to avoid cell detachment and replaced with 200 µL control BT before
imaging. After the initial, untreated, image was taken, cells were treated with 200 µL of either
additional BT (for control) or various 2X concentrations of TCS. See “Confocal Microscopy”
below for imaging details.

2.9 Confocal microcopy
For plasma membrane potential and cytosolic pH assays, an Olympus FV-1000 confocal
microscope, with an Olympus IX-81 inverted microscope and a 30 milliwatt multi-argon laser,
was used to collect images. ArcLight-A242 and ASAP2 plasmid-transfected cells were imaged
using an oil immersion 100x objective with NA 1.4 and 488 nm excitation, 505-605 nm band
pass emission filter. Lyn tailed mCherry-SEpHluorin transfected cells were imaged using oil
immersion 60x objective with NA 1.4 and 488 nm excitation, 505-525 nm emission filter. All
images were taken at 37°C using ibidi plate heating system.

2.10 Manual image analysis
All image-analysis figures in this paper were generated with this manual method except
for Figure 3.8 and Appendix Figure A.3, which were analyzed with the automated image
analysis procedure noted below. Confocal microscopy images of RBL and Jurkat cells
transfected with ArcLight and ASAP2 were analyzed manually using Fiji ImageJ software
(NIH). Well-transfected cells (i.e. visible expression of reporter and well-targeted to the plasma
membrane) were identified and a Region of Interest (ROI) was drawn on the plasma membrane
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using the free-hand tool. The area of the ROI (in units of square pixels), integrated density (=
sum of fluorescence intensity values of all pixels in the ROI), mean intensity (= integrated
density divided by area of the ROI), and length of the ROI were subsequently measured at
various specified time points before and after treatment.
Mean background fluorescence intensity (=integrated density of ROI divided by area of
ROI) for a field of view, was obtained by either drawing a square shape ROI in the cytoplasmic
region of transfected cells or by drawing an ROI around the plasma membrane of untransfected
cells. Background mean fluorescence intensity obtained through either of these methods was
subtracted from mean ArcLight fluorescence intensity of cells present in that field of view, and
the resulting value at each time point was then normalized to (divided by) its own 0 min
timepoint value of mean intensity. Both of these background subtraction methods resulted in
similar ArcLight fluorescence changes due to 20 µM TCS (data not shown). Photobleaching or
drifting effect during imaging was calculated from BT-treated (control) cells by calculating a
change in fluorescence values from 0 min. This change value was added/subtracted back to the
treatment groups to account for these non-treatment effects and thus allowing measure of the true
effect of a drug. Normalized values from multiple cells were averaged and used to generate line
plots.

2.11 Automated image analysis
In FIJI image J, individual images at different time points (0, 2, 5, 7, and 15 min) were
converted to 8-bit stack. Background fluorescence was subtracted from the stack using pseudo
flatfield correction. Next, by applying threshold, binary masks of the entire cell and only cytosol
were created. Both of these masks were applied to transfected cells to obtain area of the ROI,
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integrated density, and mean intensity values. To find the area of the ROI, mean intensity and
integrated density of plasma membrane, values of cytosol were subtracted from the area of the
ROI and integrated density of whole cell. The calculated integrated density was divided by the
calculated area of ROI. This will give mean fluorescence intensity of the plasma membrane.
Mean intensity at different time points of an individual cell was normalized to (divided by) its
own 0 min time point value of mean intensity. Fluorescence was adjusted for drifting or
photobleaching as described in “Manual Image Analysis” methods above. This automated
method was utilized to generate Figure 3.8 and Appendix Figure A.3.

2.12 Analysis of triclosan effects on ArcLight-A242 fluorescence intensity as a function of
initial ArcLight-A242 expression level
Initial (0 min) mean plasma membrane fluorescence intensity of ArcLight for each
individual cell was noted. Next, for each individual cell, the percentage drop in ArcLight
fluorescence mean intensity incurred by 15 min exposure to 20 µM triclosan (or to control BT)
was then plotted as a function of that cell’s initial mean intensity of ArcLight (its expression
level of the construct). Linear regression analysis was performed, and the slope of the best-fit
line and R2 value was determined for each plot.

2.13 Apparent plasma membrane potential percentage decrease calculation
Apparent PMP percentage decrease was calculated for the treatments, cell types, and
GEVIs utilized in this study. Each normalized and photobleaching-/drift-corrected GEVI
fluorescence value was subtracted from 1 to determine change in fluorescence due to treatment.
This result was subsequently multiplied by its respective reporter’s PMP to fluorescence change
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ratio to calculate mV change as reported by each construct. For ArcLight-A242, this ratio is 100
mV for every 35% decrease in fluorescence (100 mV/0.35) (Jin et al., 2012). For ASAP2, this
ratio is 100 mV for every 39% decrease in fluorescence (100 mV/0.39) (Chamberland et al.,
2017). This change, in units of mV, was then divided by the resting PMP of the corresponding
cell type, RBL mast cell (-82.5 mV is the average value from two patch-clamp studies (Lindau
and Fernandez, 1986; Wischmeyer et al., 1995)) or T cell (-60 mV)(Sarkadi et al., 1990) to
determine the (unitless) change in total resting cell PMP. Finally, this result was subsequently
subtracted from 1 and multiplied by 100 to obtain the apparent PMP percentage.

2.14 TCS cytotoxicity on Jurkat cells
Trypan blue exclusion and lactate dehydrogenase (LDH) cytotoxicity assays were used to
assess TCS cytotoxicity on Jurkat cells. In the trypan blue exclusion assay, 1 million cells were
plated into each of 3 wells of a 24-well, flat-bottom cell culture plate (Costar) for TCS (Sigma)
treatment and 3 wells for the control. Immediately after plating, BT and 2X TCS doses were
added to respective wells. Next, cells were incubated for 30 minutes at 37℃/5% CO2. After the
incubation, a small sample was taken from each well and mixed 1:1 with trypan blue dye (0.4%,
Lonza) evenly. Cells were counted using a hemocytometer for viability and TCS-treated cells
were normalized to the control. LDH cytotoxicity methods were those of Hutchinson et al., 2011
using a cytotoxicity detection kit (Roche). However, the lysis solution was added to the “high
control” in the final 15 minutes of the 1-hour TCS exposure instead of an additional 15 minutes
after the 1-hour TCS exposure (Palmer et al., 2012).
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2.15 Cytosolic Ca2+ assay
Prior to performing Ca2+ assays, widefield fluorescence microscopy was used to assess
transfection efficiency of GCaMP6 Ca2+ reporter construct in Jurkat T cells, and Ca2+ assays
were performed only on samples of highly-transfected cells. First, 8-well ibidi plates were coated
with 150 µL/well fibronectin (166 µg/ml) prepared in PBS and incubated overnight in tissue
culture incubator. The next day, Jurkat T cells were transfected with pGP-CMV-GCaMP6f (a
gift from Douglas Kim & GENIE Project; Addgene # 40755; http://n2t.net/addgene:40755;
RRID: Addgene_40755) (Chen et al., 2013) using Jurkat specific Amaxa Nucleofector
transfection kit T (Lonza). The electroporated cells were plated in phenol red-free Jurkat cell
media at ~1 million cells/well with phenol red-free media in the fibronectin pre-coated 8-well
ibidi plates. Cells were grown for 16-24 hours at 37oC/ 5% CO2. The next day, cell media was
removed carefully with a transfer pipette to avoid cell detachment and replaced with 200 µL BT,
and images were taken with a wide-field IX83 (Olympus, Waltham MA) microscope with a
Prime 95B CMOS Camera (Photometrics) and HLD117 stage (Prior Scientific) controlled by a
Proscan III. Fluorescence excitation was provided by an Xcite 120 LEDBoost (Excelitas).
Images were taken at 60x (Olympus-APON-60X-TIRF objective) using standard excitation and
emission filters for GFP (Semrock). The microscope is controlled by CellSens software v1.18
(Olympus).
For assessment of Jurkat T cell cytosolic Ca2+ levels following anti-T cell receptor (antiTCR) stimulation, a plate reader assay was performed similarly to that in (Weatherly et al.,
2018), with the following modifications. First, a 96-well, black-walled, clear-bottom plate
(Grenier) was coated overnight with 50 µL/well fibronectin (166 µg/ml) prepared in PBS
(Lonza). The next day, cells were transfected with the GCaMP6 construct as noted above and
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plated in 200 µL/well phenol red-free media in the fibronectin pre-coated 96-well plate at
330,000 cells/well. Cells were cultured overnight at 37°C and in 5% CO2. Next day, media was
carefully aspirated from wells with a micropipette to avoid cell detachment, and cells were
exposed to 100 µL/well 0.2 µg/ml (Holowka et al., 2018) Anti-TCR OKT3 monoclonal antibody
(Thermo Fisher Scientific) in combination with control BT or TCS treatments for 1 hour.
Fluorescence was measured with 485 ± 10 nm excitation and 528 ± 10 nm emission during this 1
hour. Area under the curve was determined as per methods in Weatherly et al., 2018.

2.16 Statistical analyses
All analyses were performed in Graphpad Prism. In most figures, raw values for
treatment groups were normalized to its appropriate untreated control. Biological replicates from
at least three independent experiments were averaged, and standard error of the mean (SEM) was
calculated across those independent experiments. Raw (non-normalized) values were analyzed
for mitochondria swelling and LDH release experiments (Figures 3.1, 3.6D). One-way ANOVA
followed by Tukey’s post-hoc test (α=0.05) was used to determine the significance level of most
experiments (Figures 3.2, 3.3B, 3.5, 3.6, 3.7B, 3.8, Appendix A.3 and A.4). The significance
level of the FPALM mitochondrial volume and surface area were assessed using an unpaired
one-tailed t-test (Figure 3.1). The significance level of the cytosolic Ca2+ level area under the
curve (AUC) of Jurkat cells was assessed via paired t-test (Figure 3.9B). Significance is
represented by ***p<0.001, **p<0.01, and *p<0.05.
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CHAPTER 3
RESULTS

3.1 Triclosan increases mitochondrial volume and surface area in RBL-2H3 mast cells:
Indicators of inhibited mitochondrial membrane potential
Previously, an organic dye fluorescence method (without imaging) revealed that TCS
inhibits MMP (Weatherly et al., 2018). To test this finding at the nanoscale, three-dimensional
super-resolution FPALM imaging (Huang et al., 2008; Parent and Hess, 2019) was employed to
assess TCS effects on 3D mitochondrial morphology, changes in which are linked to inhibition
of MMP (Guillery et al., 2008; Giedt et al., 2012; Weatherly et al., 2018). RBL cells were
transiently transfected with Dendra2-TOM20 (Weatherly et al., 2018), a construct used to label
the outer membrane of mitochondria. The next day, cells were exposed with TCS or BT control
for 1 hour, then fixed using paraformaldehyde.
While the TCS effects on mitochondrial volume and surface area were not dramatic
visually, they were statistically significant when analyzed quantitatively. Triclosan statistically
significantly increases the mean volume, as calculated by the convex hull method, by 17%
compared to control (Figure 3.1A). Also, triclosan increases the mean mitochondrial surface
area, as calculated by the alpha shape method, by 19% (Figure 3.1B). Thus, TCS modulates the
surface area and volume of individual mitochondria, as assessed with 3D FPALM superresolution microscopy.
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Figure 3.1. Triclosan effects on mitochondrial volume and surface area in RBL mast cells.
Super-resolution FPALM 3D images of Dendra2-TOM20, which labels outer mitochondrial
membranes, were processed through custom-built MATLAB code in which an algorithm
identifies individual mitochondria. As detailed in Chapter 2, (A) average mitochondrial volume
was calculated by the convex hull method, and (B) average mitochondrial surface area was
calculated by the alpha shape method. Values presented are mean ± SEM for total of 62 cells in
three independent experiments, where each independent experiment had 8-11 cells for each
condition (0 vs. 20 µM triclosan). Statistically significant results are represented by **p<0.01
and ***p<0.001 as compared to control (0 µM TCS) for volume and surface area, respectively,
as determined by unpaired t-test.
3.2 Plasma membrane potential depolarizer gramicidin potently inhibits the degranulation
of RBL-2H3 mast cells
To determine the effects of the canonical plasma membrane depolarizer, gramicidin, on
RBL mast cell degranulation, an adapted fluorescence-based β-hexosaminidase release assay
(Weatherly et al., 2013) was employed. A multivalent DNP (dinitrophenol)-BSA Ag was used
to laterally crosslink IgE-bound FcεRI receptors, thus initiating an allergic/pro-inflammatory
signal transduction that ends with the release of granules containing bioactive substances
including β-hexosaminidase, which is monitored fluorometrically. Gramicidin depolarizes cells
by forming an ion channel at the plasma membrane, allowing for free passage monovalent ions
such as H+, NH4+, K+, Na+, and Li+ down their concentration and electrochemical gradients, and,
thus, depolarizing the plasma membrane (Myers and Haydon, 1972; Mohr and Fewtrell, 1987b).
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Figure 3.2A presents the results for IgE-sensitized RBL cells incubated for 1 h in
Tyrodes—BSA (BT) buffer containing a 0.0004 µg/ml Ag dose, with gramicidin or DMSO
vehicle. All tested gramicidin doses, as low as 0.1 µM, inhibit degranulation, reducing the
response down to the same level as the spontaneous group (unstimulated with Ag). These data
indicate a potent, plasma membrane depolarization-mediated inhibition of degranulation. A
similar, but slightly less potent, gramicidin-induced depression of degranulation can be seen in
the group treated with the higher Ag dose, 0.001 µg/ml Ag (Figure 3.2B). In this case,
statistically significant inhibition of degranulation does not begin until 0.5 µM gramicidin and
appears to proceed in a dose-responsive fashion. Such data coincide with the previously reported
observation that pharmacologically induced inhibition of degranulation occurs at lower toxicant
doses when cells are stimulated at a low level (0.0004 µg/ml Ag) than when stimulated at a high
level (0.001 µg/ml Ag) (Palmer et al., 2012).
A dose comparison study for gramicidin and TCS was performed as part of testing the
hypothesis that TCS inhibits degranulation via PMP inhibition, by repeating the above
experiments with TCS in place of gramicidin at equivalent antigen and DMSO concentrations.
While DMSO is not needed/used here to dissolve the TCS, it was included to match the
conditions of the gramicidin experiments. Statistically significant, dose-responsive inhibition of
mast cell degranulation by TCS is reported in Figures 3.2C and 3.2D, beginning at 10 µM
(Figure 3.2C). This observation recapitulates previously observed TCS-mediated inhibition of
degranulation (Palmer et al., 2012), but the presence of DMSO reduces its potency: 10 µM TCS
inhibits 0.0004 µg/ml Ag-stimulated degranulation by about one-half in the absence of DMSO
(Weatherly et al., 2013) and only by about one-third in the presence of 0.003% DMSO (Figure
3.2C). Also, the TCS inhibitory effect lessens in the presence of higher Ag dose (0.001 µg/ml
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Ag; Figure 3.2D), as noted with gramicidin Figure 3.2B. Overall, depolarizer-mediated
inhibition of degranulation (Figure 3.2A and 3.2B) proceeds similarly as that of TCS, though
gramicidin is more potent than TCS, especially in the presence of DMSO. The result strengthens
the connection between PMP inhibition and degranulation inhibition.

Figure 3.2 Relative degranulation response of antigen-stimulated RBL mast cells exposed
to micromolar doses of the canonical plasma membrane depolarizer gramicidin (A and B)
or to triclosan (C and D). IgE-sensitized cells were stimulated for 1 h with either
0.0004 μg mL− 1 Ag (A and C) or 0.001 μg mL− 1 Ag (B and D). All samples (A - D) contained
0.003% DMSO, which was the vehicle required for gramicidin dissolution. For spontaneous
release (“Spont” on x-axes), cells were incubated for 1 h in BT with 0.003% DMSO (with no
IgE, Ag, TCS, or gramicidin). Values represent the mean ± SEM of 3 independent experiments;
three replicates per treatment type were used each experimental day. Statistically significant
results, as compared to the appropriate control (0 μM TCS + DMSO vehicle) or (0 μM
gramicidin + DMSO vehicle), are represented by *p < 0.05, **p < 0.01, ***p<0.001 as
determined by one-way ANOVA followed by Tukey's post-hoc test.
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3.3 Gramicidin and triclosan depress ArcLight-A242 fluorescence in RBL-2H3 mast cells.
Gramicidin, a known depolarizer of PMP, strongly inhibits degranulation (Figs. 3.2A and
2B), and TCS also reduces degranulation (Palmer et al., 2012). Also, TCS depolarizes the MMP
(Weatherly et al., 2018) (Figure 3.1). Thus, we hypothesized that TCS also inhibits the PMP, as
its underlying mechanism of degranulation inhibition. To do so, an organic voltage-sensitive
fluorescent dye, DiSC3(5) was employed. However, when TCS (micromolar levels) and
DiSC3(5) (1 µM) (Te Winkel et al., 2016) are mixed together in the absence of cells, TCS
chemically quenches the fluorescence of DiSC3(5) in a dose-response manner (data not shown);
thus, DiSC3(5) cannot be used to accurately measure TCS effects on PMP. Triclosan quenching
of unprotected fluorophores (such as those found in various voltage-sensitive, fluorescent
organic dyes) has previously been observed (Weatherly, 2017; Weatherly et al., 2018). Thus, to
measure TCS effects on PMP, genetically encoded voltage indicators (GEVIs), which contain βbarrel protein structures which may protect their fluorophores from chemical quenching or
aggregation effects (Chalfie and Kain, 2005), were used. Triclosan does not interfere with the
fluorescence of the fluorescent protein within the reporter construct GCaMP (Weatherly et al.,
2018).
To measure PMP of cells using a GEVI, RBL cells were transiently transfected with
ArcLight-A242 (ArcLight) (Jin et al., 2012) (Figure 3.3A). The next day, confocal images were
collected for each cell at different time points, up to 15 minutes, before (Figure 3.3A) and after
(Figure 3.3B) addition of control (BT), TCS, or gramicidin. Fluorescence obtained was
quantified using FIJI image J (Manual Image Analysis methods in Chapter 2) and normalized to
the 0 min time point for each condition. Gramicidin, a known PMP depolarizer, statistically
significantly reduces ArcLight fluorescence within 2 min of exposure and by 23% (± 2% SEM)
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at the end of 7 minutes. TCS, at 20 µM, statistically significantly lowers ArcLight fluorescence
within 5 min of exposure and by 25% (± 3% SEM) at the end of 15 min. This result was further
confirmed by an automated image analysis method (Appendix Figure A.3). The 10 µM TCS
data suggest an inhibition of ArcLight fluorescence by 15 min but were not statistically
significant. The decrease in ArcLight fluorescence suggests that both gramicidin and TCS
inhibit mast cell PMP.

Figure 3.3. Triclosan and gramicidin effects on fluorescence of ArcLight-A242 in RBL mast
cells. (A) One representative live-cell confocal microscopy image of an RBL mast cell
transiently transfected with ArcLight construct, prior to gramicidin or TCS treatment. Scale bar,
10 µm. (B) RBL cells were transiently transfected with ArcLight, washed with BT, exposed to
control (BT) (N = 52), 10 μM TCS (N = 22), 20 μM TCS (N = 28), or 1 μM gramicidin (N = 24)
for 15 minutes. At each time point, the average fluorescence of each plasma membrane was
measured, background-subtracted, and normalized to the 0 min timepoint, as described in
Chapter 2. Values presented are means ± SEM of at least 3 independent days of experiments per
treatment. Statistically significant results, as compared to the appropriate control (0μM TCS or
0μM gramicidin + DMSO vehicle), are represented by **p < 0.01, ***p < 0.001, as determined
by one-way ANOVA followed by Tukey's post-hoc test.
Since gramicidin treatment contained DMSO vehicle (0.003%), it was important to
determine whether gramicidin’s effects on ArcLight fluorescence are modulated by the presence
of DMSO. Thus, a control experiment was performed by repeating the gramicidin-ArcLight
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experiments in the presence of varying DMSO concentrations. Gramicidin’s ability to inhibit
ArcLight fluorescence is unaffected by increasing DMSO concentrations, ranging from 0.003%
to 0.02% (Appendix Figure B.1, B.2).
After experiments with transiently-transfected cells were successfully conducted,
ArcLight stably-transfected cell lines were created, with the goal of enabling high-throughput
testing of numerous concentrations of triclosan and other toxicants, as well as additional time
points. However, unfortunately, clones of RBL cells stably transfected with ArcLight display
construct aggregation and poor plasma membrane localization (Appendix Figure A.4).
To check whether plasmid expression level affects the change in GEVI fluorescence in
response to triclosan, the initial, 0 min (pre-triclosan-exposure), background-subtracted mean
fluorescence intensity of each individual cell from Figure 3.3’s data was analyzed. The
percentage drop in ArcLight fluorescence by 15 minutes time of exposure (control buffer-treated
in 3.4A, TCS-treated in 3.4B), for each individual cell, was plotted as a function of that
particular cell’s initial mean intensity of ArcLight. There is no correlation between plasmid
expression level and the magnitude of TCS inhibition of ArcLight fluorescence (Figure 3.4B), as
analyzed by linear regression. Thus, TCS effects on GEVI fluorescence are unaffected by the
“brightness” (GEVI expression level) of the cell.
In a random sample of 7 cells treated with 20 µM TCS, fluorescence distribution around
the plasma membrane was obtained using the plot profile feature in Image J. Fluorescence values
were obtained every 0.159 micron (=1 pixel) around the plasma membrane for individual cells, at
0 and 15 min post TCS treatment. Cells at 0 minute time point display a ~30% standard deviation
in fluorescence pixels around each individual cell, similar to this distribution in cells that were
exposed to triclosan for 15 minutes. This variation in fluorescence around the cell may be due to
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differential delivery of constructs to different parts of the plasma membrane, differences in cell
morphology at the chosen confocal slice imaged, or another reason. This ~30% average random
error in Arclight fluorescence at various positions within the plasma membrane did not vary due
to the presence or absence of triclosan. In contrast, in Figure 4, the triclosan data (4B) shows
greater spread among individual cells than does the control data (4A), strongly suggesting that
the spread in data due to triclosan is truly due to variable cellular responses to triclosan rather
than due to and not due to pixel-by-pixel random error in fluorescence. Despite their clonality,
individual RBL-2H3 mast cells are well known to respond variably to external stimuli (Millard et
al., 1988). Additionally, when standard deviation as a percentage of fluorescence values is
plotted against distance around the plasma membrane, a fairly random distribution is seen in both
groups of 0 and 15 minute TCS treated cells (data not shown). Together, these analyses bolster
the conclusion that depression of Arclight fluorescence due to TCS exposure is a true cellular
effect that is greater than random error.

Figure 3.4. Effect of cellular expression level of ArcLight-A242 on TCS inhibition of
ArcLight-A242 fluorescence. Data from Figure 3.3B, ArcLight-A242 transfected cells
analyzed by confocal imaging and image analysis comparing control (0µM TCS) and 20µM TCS
treatments, were plotted as individual cells’ data. The percentage drop in fluorescence by 15
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minutes time of exposure, for each individual cell, is plotted as a function of that cell’s initial
mean intensity of ArcLight-A242. Statistical results per plot are represented by equation of linear
regression and R2 values.
Plasma membrane depolarization causes ArcLight fluorescence intensity to decrease, in a
linearly proportional fashion (Jin et al., 2012). PMP percentage decline can be calculated from
the measured change in ArcLight fluorescence, as outlined in Chapter 2. This apparent mast cell
PMP, as a percentage of initial, 0 min, pre-triclosan-exposure value, is plotted as a function of
time following TCS or gramicidin exposure (Figure 3.5). Within 7 min of exposure to 1 µM
gramicidin, RBL mast cell PMP appears to decrease by 79% (± 7% SEM) of initial resting PMP,
in a time-responsive manner. Similarly, within 15 min of exposure to 20 µM TCS, RBL cell
PMP appears to decrease by 90% (± 11% SEM). There appears to be a modest, but not
statistically significant, decline in PMP within 15 min exposure to 10 µM TCS.
Triclosan inhibits ArcLight fluorescence, and, thus, apparently inhibits RBL cell PMP.
Thus, the next experiments tested whether these results are extendable to another immune cell
type which is also dependent on PMP and SOCE for its function, T-cells.
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Figure 3.5. Triclosan and gramicidin apparent effects on plasma membrane potential
(PMP) of RBL mast cells. Data from Figure 3.3B were utilized to calculate percentage of PMP
(with each 0 min timepoint defined as 100%) as a function of time (min), as described in Chapter
2. Values presented are means ± SEM of at least 3 independent days of experiments per
treatment. Statistically significant results, as compared to the appropriate control (0 μM TCS or
0 μM gramicidin + DMSO vehicle), are represented by ***p < 0.001, as determined by one-way
ANOVA followed by Tukey's post-hoc test.
3.4 Non-cytotoxic doses of triclosan depress ArcLight-A242 fluorescence in Jurkat T cells.
To measure triclosan effects on PMP of T cells, human Jurkat T cells were transiently
transfected with ArcLight. The next day, confocal images were collected for each cell at
different time points, up to 15 minutes, before and after addition of control (BT) or TCS (Figure
3.6A). Fluorescence obtained was quantified using FIJI image J (Manual Image Analysis
methods in Chapter 2) and normalized to the 0 min time point for each condition. TCS, at 20
µM, lowers ArcLight fluorescence within 2 min of exposure and by 31% (± 3% SEM) at the end
of 15 min (Figure 3.6A). The decrease in ArcLight fluorescence suggests that TCS inhibits T
cell PMP.
This apparent T cell PMP was calculated (see Chapter 2) as a percentage of initial, 0 min,
pre-triclosan-exposure value and is plotted as a function of time following TCS exposure (Figure
3.6B). Within 15 min of exposure to 20 µM TCS, T cell PMP appears to decrease to -150% (±
15% SEM) of initial resting PMP, apparently a more-than-complete dampening of T cell PMP.
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Figure 3.6. Triclosan effects on fluorescence of ArcLight-A242 in human Jurkat T cells,
triclosan apparent effects on Jurkat plasma membrane potential (PMP), and cytotoxicity
determination. (A) Jurkat cells were transiently transfected with ArcLight-A242, washed with
BT, exposed to BT (0 µM TCS) (N=20) or 20 µM TCS (N=17) for 15 minutes. At each time
point, the average fluorescence of each plasma membrane was measured, background-subtracted,
and normalized to the 0 min timepoint, as described in Chapter 2. (B) Data from Figure 3.6A
were utilized to calculate percentage of PMP (with each 0 min timepoint defined as 100%) as a
function of time (min), as described in Chapter 2. (C) Jurkat T cell cytotoxicity to TCS was
assessed by trypan-blue exclusion assay and by (D) lactate dehydrogenase (LDH) detection kit
from Roche. “High control” is a sample treated with lysis solution provided by the kit. Values
presented are mean ± SEM of at least three independent experiments. Statistically significant
results, as compared to appropriate control, are represented by **p<0.01, ***p < 0.001, as
determined by one-way ANOVA followed by Tukey’s post-hoc test.
In order to determine if the results obtained above were truly functional changes or due to
cytotoxicity from TCS, the effect of micromolar doses of TCS (0 µM, 10 µM, and 20 µM) on
Jurkat T cell viability were assessed using a trypan blue exclusion assay. Results indicate that
TCS does not cause a decrease in cell viability within a 30 min exposure (Figure 3.6C). In order
to confirm these cytotoxicity results, a more sensitive microplate reader-based assay, LDH assay
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was also performed. LDH release was measured in response to varying doses of TCS for 1 hour.
There is no significant release of LDH from TCS-treated cells as compared to control; the “high
control” sample is a positive control detecting LDH release from lysed cells (Figure 3.6D).
These data from cytotoxicity experiments indicate that TCS dosage timing and concentration
used in this study do not cause Jurkat T cell cytotoxicity.

3.5 Triclosan does not depress the fluorescence of the genetically encoded voltage indicator
ASAP2 in RBL-2H3 mast cells.
To check the results obtained using ArcLight, an alternative GEVI, called ASAP2, which
utilizes a different voltage-sensing mechanism from that of ArcLight (Jin et al., 2012;
Chamberland et al., 2017) was used. RBL mast cells were transiently transfected with ASAP2
(Figure 3.7A). The next day, confocal images were collected for each cell at different time
points, up to 15 minutes, before (Figure 3.7A) and after (Figure 3.7B) addition of control (BT) or
TCS. Fluorescence obtained was quantified using FIJI image J (Manual Image Analysis methods
in Chapter 2) and normalized to 0 min time point for each condition. Triclosan (20 µM, up to 15
min) does not alter fluorescence of ASAP2 when compared to the 0 µM TCS control (Figure
3.7B). In stark contrast to the clear triclosan dampening of fluorescence observed with the
ArcLight reporter (Figure 3.3), these ASAP2 results (Figure 3.7B) indicate that TCS does not
change the PMP of RBL mast cells.
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Figure 3.7. Triclosan effects on fluorescence of ASAP2 in RBL mast cells. (A) One
representative live-cell confocal microscopy image of an RBL mast cell transiently transfected
with ASAP2 construct, prior to TCS treatment. Scale bar, 10 µm. (B) RBL cells were transiently
transfected with ASAP2, washed with BT, exposed to control (BT) (N=18) or 20 μM TCS
(N=21) for 15 minutes. At each time point, the average fluorescence of each plasma membrane
was measured, background-subtracted, and normalized to the 0 min timepoint, as described in
Chapter 2. Values presented are means ± SEM of at least 6 independent experiments per
treatment. Analysis by one-way ANOVA followed by Tukey's post-hoc test found no statistical
significance.
However, TCS inhibits the fluorescence of ArcLight, which contains a pH-sensitive super
ecliptic pHlourin on the cytoplasmic side of the plasma membrane. Thus, the next investigation
centered on whether TCS-induced depression of ArcLight fluorescence is due to a change in
cytosolic pH instead of a change in PMP.

3.6 Triclosan depresses fluorescence of a plasma membrane-targeted pHlourin in RBL
mast cells, indicating triclosan reduction of cytosolic pH.
To identify whether TCS affects cytosolic pH, plasma membrane-targeted fluorescence
reporter called Lyn-tailed mCherry-SEpHlourin (Koivusalo et al., 2010), which measures subplasma membrane cytosolic pH of a cell, was employed. The transfection and imaging
procedures used for the GEVI experiments were repeated, along with an automated image
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analysis technique (described in Chapter 2). Triclosan, at 20 µM, decreases mCherrySEpHlourin fluorescence intensity within 5 min of exposure and by 43% (± 2% SEM) at the end
of 15 min (Figure 3.8). This result is similar to the magnitude of triclosan’s effect on ArcLight
fluorescence (Figure 3.3), suggestive of a pH change in response to TCS rather than a PMP
change.

Figure 3.8. Triclosan effects on fluorescence of Lyn-tailed mCherry-SuperEcliptic (SE)
pHluorin in RBL mast cells. RBL cells were transiently transfected with Lyn-tailed mCherrySE pHluorin, washed with BT, and exposed to BT (N=35) or 20 μM TCS (N=52) for 15 minutes.
At each time point, the average fluorescence of each plasma membrane was measured,
background-subtracted, and normalized to the 0 min timepoint, as described in Image J
Automated methods in Chapter 2. Values presented are means ± SEM of 3 independent days of
experiments per treatment. Statistically significant results, as compared to the appropriate
control (0μM TCS), are represented by ***p < 0.001, as determined by one-way ANOVA
followed by Tukey's post-hoc test.
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3.7 TCS inhibits cytosolic Ca2+ response to Anti-T Cell Receptor stimulation in Jurkat T
cells
TCS affects Ca2+ dynamics and inhibits SOCE in mast cells (Weatherly et al., 2018).
Due to the similar triclosan depression of ArcLight fluorescence in Jurkat T cells (Figure 3.6A)
as in RBL mast cells (Figure 3.3B), we hypothesized that a similar calcium effect also occurs in
Jurkat T cells. To test this hypothesis, Jurkat T cells were transfected with Ca2+ reporter
construct GCaMP6 (Chen et al., 2013). The next day, cells were stimulated with 0.2 µg/ml AntiT Cell Receptor (TCR) OKT3 ± TCS (Holowka et al., 2018), and cytosolic Ca2+ was measured
throughout the duration of 1 hour. Cells were transfected at a highly efficient rate (Appendix
Figure A.5). Following anti-TCR stimulation, an initial rise in Ca2+ is seen within the first few
minutes, followed by a plateau Ca2+ level above unstimulated basal level (compare “0 µM TCS +
Ab” to “Unstimulated” curves in Figure 3.9A), as expected (Holowka et al., 2018). TCS, at 20
µM, inhibits Ca2+ levels in comparison to the control in anti-TCR activated cells, in particular by
flattening the plateau region (Figure 3.9A). Triclosan minimally affects the initial Ca2+ rise but
heavily dampens calcium in the plateau region, similar to its effects in RBL mast cells
(Weatherly et al., 2018). AUC analysis reveals an average decrease of 70% (± 17%) integrated
Ca2+ levels in anti-TCR activated cells with TCS treatment compared to that of activated control
(Figure 3.9B). These data indicate that TCS inhibits cytosolic Ca2+ signaling in T cells.
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Figure 3.9. Triclosan effects on cytosolic Ca2+ levels as activated by anti-T Cell Receptor
(TCR) antibody in Jurkat T Cells. Jurkat cells were transiently transfected with cytosolic
GCaMP6 overnight, then exposed in BT Control or 20 μM TCS, each with 0.2 µg/ml anti-TCR
(“Ab”) for 1 hour. “Unstimulated” contained no TCS and no anti-TCR. Raw fluorescence was
measured using a microplate reader as described in Chapter 2. (A) Representative figure (no
error bars) shows fluorescence obtained following background fluorescence subtraction (mocktransfected cells’ fluorescence) from treatment groups at each time point. (B) Area under the
curve (AUC) was obtained from the fluorescence curves and values were normalized to the
control of each day for 3 replicates per treatment group per day. AUC values presented are
means ± SEM of 3 independent days of experiments. Statistically significant results, as
compared to the appropriate control (0μM TCS), are represented by *p < 0.05, as determined by
unpaired t-test.
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CHAPTER 4
DISCUSSION
Triclosan disrupts mast cell function, rapidly (within tens of minutes) and at noncytotoxic concentrations relevant to consumer product exposure (Palmer et al., 2012; Shim et al.,
2019), but the underlying biochemical mechanism was unknown. In this study, we unraveled the
mode of action of TCS in mast cells and replicated these TCS effects in another immune cell
type, T cells.
The process of deciphering the mechanism began with two observations: TCS is a
mitochondrial uncoupler (Weatherly et al., 2016; Weatherly et al., 2018) and also a disruptor of
the central signal for mast cell degranulation—cytosolic Ca2+ rise (Weatherly et al., 2018). As
an uncoupler, TCS depresses the MMP, which results in mitochondrial fragmentation, observed
in live cells with super-resolution microscopy (Weatherly et al., 2018). Mitochondrial toxicity
and deformation are important markers of TCS toxicity in numerous cell types and species (Shim
et al., 2016; Weatherly et al., 2018; Weatherly et al., 2020). Disruption of mitochondrial shape
plays a role in diseases such as cognitive decline (Hara et al., 2014), Parkinson’s disease (Cui et
al., 2010; Bhandari et al., 2014), insulin resistance (Jheng et al., 2012), immune dysfunction
(Weatherly et al., 2020), inflammation (Compan et al., 2012), and disrupted embryonic
development (Chen et al., 2003). In this study (Figure 3.1), we have augmented these findings
by utilizing 3D super-resolution FPALM to reveal TCS enhancement of mitochondrial surface
area and volume, indications of mitochondrial swelling and MMP disruption (Guillery et al.,
2008; Giedt et al., 2012). This increase in surface area and volume has also been observed in
neuronal mitochondria due to exposure to carbonyl cyanide-4
(trifluoromethoxy)phenylhydrazone (FCCP), a known proton ionophore and MMP depolarizer
(Safiulina et al., 2006). The connections between mitochondrial deformation and disrupted MMP
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are extended to PMP depolarization, inhibited store-operated calcium entry (SOCE), and,
subsequently, dampened mast cell degranulation via studies with a similar proton ionophore
mitochondrial uncoupler, carbonyl cyanide m-chlorophenylhydrazone (CCCP), which also
inhibits MMP, PMP, SOCE, and mast cell degranulation (Mohr and Fewtrell, 1987b).
Triclosan’s enhancement of mitochondrial surface area and volume led to a PMP collapse
hypothesis as the mode of action of immune cell dysfunction.
Data from figure 3.1 were replotted to obtain a relationship between surface area and
volume of mitochondria of control and 20 µM TCS treated cells. Figure 4.1 shows variation in
cell responses to control and TCS, showing that when mitochondria in cells increase in surface
area due to TCS, they also increase in volume linearly. However, due to complexity of
mitochondria and their networks, we cannot conclude if this uniform change is reflected in
mitochondria shape.

Fig 4.1. Relationship between mitochondrial surface area and volume. Data from figure 3.1
were replotted to get a relationship between mitochondrial surface area and volume from control
(A) and 20 µM TCS (B) treated cells. Statistical results in the plot are represented by equation of
linear regression and R2 values.
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Thus, we hypothesized that TCS inhibits not just MMP but also PMP. Direct evidence
for this hypothesis was provided by reports that TCS induces a current (evidence of its proton
ionophore nature) across artificial membranes (Popova et al., 2018) and depolarizes neuronal
PMP (Arias-Cavieres et al., 2018; Popova et al., 2018) at micromolar doses within tens of
minutes. As calculated in the Introduction, a complete depolarization of PMP in mast cells
would lead to a ~45% reduction in the driving force for cytosolic Ca2+ influx into the cell
through activated CRAC channels; indeed, Weatherly et al., 2018 reported ~45% decrease in
cytosolic calcium levels after TCS exposure in RBL mast cells. This study also reports (Figure
3.9) a robust decrease in cytosolic calcium levels after TCS exposure in Jurkat T cells. In turn,
the decrease in cytosolic Ca2+ inhibits degranulation (Holowka et al., 2012). Additionally, the
known PMP depolarizer gramicidin inhibits mast cell degranulation in parallel conditions to TCS
mast cell disruption (Figure 3.2), lending further support for the PMP collapse hypothesis for the
TCS mode of action.
To measure TCS effects on PMP, two genetically encoded voltage indicator (GEVI)
reporter constructs, ArcLight-A242 (ArcLight) (Jin et al., 2012) and ASAP2 (Chamberland et
al., 2017), were utilized. ArcLight senses changes in PMP due to its two specialized subunits: a
transmembrane voltage-sensing domain which, upon changes in PMP, undergoes conformational
changes that cause conformational changes in the attached green fluorescent protein (GFP)derived, super ecliptic pHlourin fluorescent domain which is localized intracellularly, in the
cytosol. ASAP2 also contains a transmembrane voltage-sensing domain but, in contrast to
ArcLight, ASAP2 contains an extracellularly-located, circularly-permuted (non-pHlourin-based)
fluorescent GFP (cpGFP) domain. For both of these GEVIs, their fluorescence intensity
decreases upon PMP depolarization. These experiments yielded drastically different results:
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Triclosan inhibits ArcLight fluorescence in RBL mast cells (Figure 3.3) and in Jurkat T cells
(Figure 3.6), suggesting TCS-induced collapse of PMP in these cell types (Figures 3.5 and 3.6).
Note that the effect was not statistically significant with 10 µM TCS but did suggest a modest
inhibition at that dose/timeframe. In contrast, TCS had no effect on ASAP2 fluorescence (Figure
3.7). While both ArcLight and ASAP2 are plasma membrane voltage-sensitive, there is a crucial
difference in their structures: the location and pH sensitivity of their fluorescent protein
domains. ArcLight’s fluorescent domain is a pHlourin, which is strongly pH-sensitive in the
physiological pH range (Jin et al., 2012) (Supplemental Figure 2B from this article shows that a
pH reduction from 7.5 to 6.5 would drastically reduce this pHlourin’s intensity, by ~50% or
more). It is located in the cytosol, so it reports changes in cytosolic pH, with acidification
leading to fluorescence intensity decline. ASAP2 cannot report cytosolic pH changes because its
fluorescent domain is located outside the cell, unless those changes affect the PMP (personal
communication, Dr. Francois St-Pierre). Interpretation of the ASAP2 data is somewhat
confounded by the fact that its cpGFP fluorescent domain is also somewhat pH sensitive
(Miyawaki and Niino, 2015; Kostyuk et al., 2019). It is possible that TCS could cause
extracellular acidification, which would affect ASAP2 fluorescence, as a consequence of its
mitochondrial toxicity, but a previous report of extracellular acidification due to TCS exposure
was shown after 44 hours of exposure (Ajao et al., 2015) while our GEVI experiments were
completed in 15 min. Also, if TCS were acidifying the extracellular space around the RBL mast
cells and Jurkat T cells within the experimental exposure time (15 min), overcoming the
buffering of the BT solution, a decrease in ASAP2 fluorescence would have occurred
(Stepanenko et al., 2008). Together, these data suggest that TCS does not affect mast cell or T
cell PMP but, instead TCS lowers cytosolic pH.
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Indeed, TCS acidifies the cytosol, as measured with lyn-tailed mCherry-SEpHluorin, a
pH-sensitive, PMP-insensitive reporter construct (Figure 3.8). ArcLight and lyn-tailed mCherrySEpHluorin share the same pH-sensitive fluorophore, the super ecliptic pHlourin (Koivusalo et
al., 2010; Jin et al., 2012). A decrease in lyn-tailed mCherry-SEpHluorin’s fluorescence is
equivalent to a cytosolic pH decrease (Koivusalo et al., 2010). This intracellular pH effect may
either be localized, or be most drastic, near the plasma membrane itself as both of these pHsensitive reporters are plasma membrane-localized (Koivusalo et al., 2010; Jin et al., 2012).
As noted in Chapter 2, a 35% decrease in the fluorescence intensity of ArcLight corresponds
with a 100 mV PMP decrease (Jin et al., 2012); thus, a 29% decrease in fluorescence intensity
would correspond with a complete depolarization of the RBL cell PMP (~82.5mV) (Lindau and
Fernandez, 1986; Wischmeyer et al., 1995). Thus, if the ArcLight response were measuring PMP
changes in response to TCS, the maximum response of any cell should have been ~29%. On the
contrary, nearly half of cells responded to TCS exposure with a greater-than-29% drop in
ArcLight fluorescence (Figure 3.4). Some of this variation is likely due to cell-to-cell variation
in signaling, even in this clonal cell line (Millard et al., 1988).
However, because ArcLight’s fluorescence can also communicate changes in pH and can
be depressed nearly 100% within a 1 pH unit acidification starting at normal physiological pH
(Jin et al., 2012), the cell-to-cell variation of TCS response in Figure 3.4 provides further
evidence for TCS acidification of the cytosol.
Taking into account the pH sensitivity of its fluorophore (Jin et al., 2012), the ArcLight
data (Figure 3.3) can be re-interpreted as a 20 µM TCS-induced pH decrease of -0.23 pH units
(Table 4.1). The pH sensitivity of the fluorescence intensity of ArcLight’s super ecliptic A227D
pHlourin (plotted in the Supplement of (Jin et al., 2012)) is approximately linear between pH 6.5
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to 7.5. This relationship can be approximated using the following: 𝐹 = 0.6𝑝𝐻 − 3.8 where F is
the fraction of maximal fluorescence, and the equation is valid over a range of ± 0.5 pH units.
Thus, at a pH of 7.2, F = 0.52, meaning that ArcLight will exhibit 52% of its maximal
fluorescence intensity at the starting, physiological pH. The 26% ± 3% (SEM) decline in
ArcLight fluorescence due to 15 min of 20 µM TCS exposure (Figure 3.3) translates to a 26%
reduction in this 0.52 value, bringing the final, normalized, ArcLight fluorescence intensity to
0.38 ± 0.02; solving for the corresponding pH value returns a final pH value of 6.97 ± 0.02
following this TCS exposure. This yields the -0.23 pH unit decrease estimate from the ArcLight
data (Table 4.1). Additionally, the same data interpretation can be employed with lyn-tailed
mCherry-SEpHluorin, resulting in a pH decrease to 6.83 ± 0.02, yielding the -0.37 pH unit
decrease estimate (Table 4.1). These pHlourin-measured decreases in pH are similar in
magnitude, providing corroborating evidence that TCS acidifies the cytosol.

Method
Calculated estimate

Magnitude of pH Change
-0.3

Citation
Discussion

ArcLight experiments

-0.23

Figure 3.3

pHlourin experiments

-0.37

Figure 3.8

Average

-0.3

Table 4.1

Table 4.1. Summary of estimated changes in cytosolic pH following TCS exposure.
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These measured pH changes were confirmed with theoretical calculations of TCS acidbase chemistry. Taking into account the 400 µL volume of 20 µM TCS in each ibidi well
containing ~400,000 cells on each experimental day (see Chapter 2), along with an estimated
10% absorption rate (Moss et al., 2000; Weatherly and Gosse, 2017), each cell received ~5.3 x
10-15 moles, or 3.2 x 109 molecules of TCS. Considering its pKa of 7.9 (PubChem), a resting cell
cytosolic pH of 7.2 (Johnson et al., 1980; Lodish et al., 2000; Beck et al., 2014), and the
Henderson-Hasselbalch equation, 16.6% of TCS is deprotonated when it encounters the pH 7.2
resting cytosol. This 16.6% value equates to 5.3 x 108 deprotonated TCS molecules per cell, and
hence, 5.3 x 108 excess H+ delivered to each cell as this monoprotic weak acid dissociates.
While this excess proton dose, from TCS, far exceeds the proton concentration of the cell, it
rapidly encounters the cellular buffering system. Carbonate (CO2/HCO3-, pKa 6.1) buffering
(Nelson and Cox, 2017) accounts for approximately two-thirds of a cell’s total buffering power
(Boron, 2004), and average mammalian cells contain 12 mM of HCO3- (Lodish et al., 2000), the
conjugate base of this buffering system (A-); these values and the Henderson-Hasselbalch
equation can be used to calculate the concentration of the weak acid (HA) in the untreated cell:
0.953 mM. The average mammalian cell has a volume of 1766 μm3 (Barrandon and Green,
1985), and the cytosol itself accounts for 70% cellular volume (Luby-Phelps, 2000). Thus, the
volume of the cytosol is 1236 μm3 or 1.236 x 10-12 L. Multiplying this volume by the HA and Aconcentrations noted above and by Avogadro’s number yields the number of HA and Amolecules found within the cytosol of an untreated cell: 7.1 x 108 HA molecules and 8.9 x 109
A- molecules. The 5.3 x 108 excess H+ delivered to the cell by TCS exposure interact 1:1 with
these A- molecules, thereby producing 5.3 x 108 new HA molecules added to the original pool of
HA molecules and subtracted from the original pool of A- molecules: resulting in 1.24 x 109

41

molecules of HA and 8.4 x 109 A- molecules. Plugging these values into the HendersonHasselbalch equation leads to a cytosolic pH of TCS-treated cells of 6.9: a -0.3 pH depression
caused by TCS exposure (Table 4.1). In fact, the average of the pH depressions captured in the
ArcLight and lyn-tailed mCherry-SEpHluorin measurements is -0.3, in agreement with this
calculated value.
Acidification of the cytosol has been shown to decrease Ca2+ release-activated Ca2+
current (ICRAC), the final step in SOCE, in several cell types including RBL and Jurkat T cells
expressing stromal interaction molecule 1 (STIM1) and ORAI1 (Beck et al., 2014). In this study,
the cytosol of each assayed cell was acidified via direct introduction of NaOH or HCl via pipette.
A stepwise effect, reduction of ICRAC occurred upon decreasing the pH from 7 to 6. Triclosanmediated acidification of the cytosol may thus explain the previously observed inhibition of Ca2+
dynamics (Weatherly et al., 2018) and, thus, of degranulation (Holowka et al., 2012).
Another proton ionophore mitochondrial uncoupler, CCCP, also inhibits Ca2+ influx into
RBL mast cells (Mohr and Fewtrell, 1987b). While this effect is partly caused by CCCP’s
depolarization of PMP (Mohr and Fewtrell, 1987b), it can also be reversed by increasing the pH
(i.e. alkalization) of the surroundings (Mohr and Fewtrell, 1987b) and, hence, of the cytosol
because H+ becomes plasma membrane-permeant when CCCP is incorporated into the
membrane (McLaughlin and Dilger, 1980). These findings suggest that CCCP inhibition of
SOCE is partly caused by its pH modulation. Additionally, experiments on isolated neurons have
shown that another proton ionophore mitochondrial uncoupler, FCCP, also acidifies the cytosol
(Tretter et al., 1998). Therefore, TCS is acting as expected, from its proton ionophore
mitotoxicant nature, in acidifying the immune cell cytosol and, then, inhibiting SOCE.
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While under some conditions acidification of the cytoplasm can inhibit SOCE by
blocking the binding of IP3 to its receptor on the ER (Tsukioka et al., 1994), release of Ca2+ from
the ER is actually enhanced in TCS-treated mast cells (Weatherly et al., 2018). Following antiTCR activation of SOCE in T cells, the initial rise of Ca2+ release from the ER is largely
unaffected by TCS whereas the plateau region representing SOCE via CRAC channels is heavily
reduced by TCS (Figure 3.9), further evidence that IP3 receptor interference is not the key
mechanism of TCS inhibition in T cells, as well. Instead, it is likely that TCS-induced cytosol
acidification blocks the proper interaction of the STIM and ORAI1 machinery that is required for
CRAC channel opening (Thompson et al., 2009; Mancarella et al., 2011). Histidine 155, found
between transmembrane domain (TM) 2 and 3 of ORAI1, plays an important role in sensing
intracellular pH (Tsujikawa et al., 2015). Upon cytoplasmic acidification, H155 becomes
protonated and affects intermolecular interaction of other components in the loop between TM2
and TM3 of the ORAI1 that may result in CRAC channel closing (Tsujikawa et al., 2015). This
histidine is conserved in rat (as in RBL cells) and human (as in the Jurkat T cells), according to
an NCBI Blast multiple amino acid sequence alignment. TCS-induced protonation and closing
of CRAC channels reduces influx of Ca2+ into mast cells (Weatherly et al., 2018) and T cells
(Figure 3.9) and inhibits mast cell function (Palmer et al., 2012).
Future research will examine inhibition of T cell functions downstream of SOCE, such as
release of essential cytokines (Punt et al., 2019). In addition to the known TCS inhibition of
mast cell degranulation and other functions (Palmer et al., 2012), TCS also inhibits the lytic
function of natural killer cells (Udoji et al., 2010; Hurd-Brown et al., 2013), which are important
defenders against cancer and viral infections.
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In addition to acidifying the cytosol by its direct proton ionophore mechanism of
providing a pathway for charged protons to flow into the cell, TCS may also be acidifying the
cell contents via other mechanisms. TCS increases the production of reactive oxygen species
(ROS) in mast cells (Weatherly et al., 2018) and in other cell types (Binelli et al., 2009; Riva et
al., 2012; Tamura et al., 2012; Yueh et al., 2014; Lv et al., 2016; Weatherly et al., 2018), which
impair the Na/H+ exchanger, leading to reduced intracellular pH (Kaufman et al., 1993;
Nakamura et al., 2006). TCS also causes mitochondrial fission/fragmentation (Weatherly et al.,
2018), processes associated with reduced intracellular pH as a result of lactic acid buildup
attributed to increased glycolysis (Johnson and Nehrke, 2010; Schurr, 2014). While the
timeframes in which these processes acidify the cell are likely longer than the rapid (within 15
min) acidification reported in this study, these mechanisms suggest that TCS will continue to
acidify the cell over longer exposure times and possibly at lower doses; ROS stimulation and
mitochondrial dysfunction occur in primary human keratinocytes, mast cells, and other cell types
at lower doses (starting ~1 µM) than the 10-20 µM used in the current study.
If this TCS acidification occurs in the mitochondria to a similar degree (~0.3 pH unit
acidification of the matrix), the driving force (Gibbs free energy) available for producing ATP on
ATP synthase in the inner mitochondrial membrane will be also reduced, as previously observed
(Weatherly et al., 2016). This effect can be estimated by calculating the driving force both in the
presence and absence of 20 µM TCS, via the equation
∆𝐺!"#$%&'"( = 2.3𝑅𝑇∆𝑝𝐻 + Ϝ∆Ψ
(Nelson and Cox, 2017). Using the 37oC temperature used experimentally, the gas and
Faraday’s constants, ∆𝑝𝐻 = -0.75, and ∆Ψ = -0.2 V (Nelson and Cox, 2017), the free energy
released by protons flowing through ATP synthase into the matrix is a robust ~-24 kJ/mol in a
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healthy cell. Taking into account a 0.3 pH unit acidification of the matrix (such that ∆𝑝𝐻 = 0.45) and a 40% reduction in ∆Ψ (Weatherly et al., 2018) due to 20 µM TCS exposure, the free
energy released by protons flowing through ATP synthase into the matrix is a weaker ~-14
kJ/mol in a TCS-treated cell. This result implies a ~40% reduction in the free energy available
for making ATP. While imperfect, this value is a reasonable match to the >50% reduction in
ATP production caused by 20 µM TCS in RBL cells (Weatherly et al., 2016).
TCS inhibits MMP (Weatherly et al., 2018); however, TCS does not inhibit PMP. This
apparent contradiction can be explained by the inherent cellular mechanisms in charge of
creating and then maintaining either the MMP or the PMP. The MMP is primarily generated by
the action of the electron transport chain (ETC) proton pumps (Nelson and Cox, 2017); MMP is
entirely reliant on this segregation of protons. TCS is a proton ionophore mitochondrial
uncoupler, thus, acting in direct opposition to the proton pumps of the ETC (Weatherly et al.,
2016). Such direct opposition, with no alternative means of MMP maintenance, serves to explain
why TCS can significantly depress the MMP. In contrast to the MMP’s generation by proton
pumping, PMP is primarily generated by the action of the Na+/K+ ATPase, (Nelson and Cox,
2017), which is located nearly exclusively on the plasma membrane (Bertorello et al., 2003) and
is not present on the mitochondrial membrane. In RBL mast cells, the Na+/K+ ATPase
contributes to PMP (Bronner et al., 1989) and resides on the plasma membrane of RBL cells, and
its inhibition leads to dampening of Ag-stimulated degranulation (Gentile and Skoner, 1996).
Thus, TCS modulation of proton concentrations could affect cytosolic pH without altering PMP.
TCS does cause PMP depolarization of artificial membranes which do not contain the Na+/K+
ATPase (Popova et al., 2018). TCS-mediated changes in proton concentrations across these
membranes would therefore not be counteracted by the Na+/K+ ATPase. TCS also causes PMP
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depolarization of neuronal models (Arias-Cavieres et al., 2018; Popova et al., 2018) at
micromolar doses within tens of minutes. Neurons heavily rely on the PMP for their function
and, while the Na+/K+ ATPase is still the primary source of this voltage, neurons possess
additional PMP regulation mechanisms (Bean, 2007), which may explain triclosan’s differential
effects on PMP of immune cells vs. neuronal cells. Interestingly, TCS inhibits Na+/K+ ATPase
activity in Labeo rohita gills (Hemalatha et al., 2019), a hint that, over longer exposure periods
than those used in the current study, TCS may interfere with cellular PMP. Na+/K+ ATPase uses
ATP to function properly (Nelson and Cox, 2017). TCS (20µM) significantly inhibits ATP
production in cells in galactose media, conditions under which they are forced to undergo
oxidative phosphorylation (Weatherly et al., 2016). Could TCS inhibit mast cell degranulation
by inhibiting Na+/K+ ATPase function through reduced ATP production? When mast cells are
placed in glucose media (BT), 20 µM TCS only inhibits ATP production by 8% (Weatherly et
al., 2016). This small inhibition of ATP does not explain the 80% reduction in degranulation,
experiments which are performed in glucose-containing media, in response to 20µM TCS
(Weatherly et al., 2016; Weatherly et al., 2018).
In conclusion, we report the mechanism of TCS inhibition of mast cells and T cells
(Figure 4.1). Three-dimensional super-resolution microscopy shows that TCS causes
mitochondrial swelling in mast cells, further evidence for its depolarization of the mitochondrial
membrane. However, TCS does not inhibit immune cells by dampening their plasma membrane
potential. Using genetically encoded voltage indicators coupled with pH-indicating reporters, we
have identified that TCS acidifies the cytosol but does not affect PMP in immune cells. Cytosolic
acidification disrupts the Stim1-Orai1 interaction, causing CRAC channel closing and collapse of
Ca2+ influx into mast cells and T cells. TCS-induced reduction of Ag-stimulated cytosolic Ca2+
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influx results in inhibited enzymatic activity and decreased microtubule polymerization, leading
to suppression of mast cell degranulation. Collapse of SOCE in T cells also likely leads to
inhibition of T cell function. Any cell type that depends on Ca2+ signaling or mitochondrial
function is susceptible to TCS toxicity (Feske, 2007; Hill-Eubanks et al., 2011). In summary,
TCS, a mitochondrial toxicant, is also an immunotoxicant via its modulation of immune cell
signal transduction.

Figure 4.2. Schematic diagram of TCS effects on mast cell degranulation through CRAC
channel inhibition. When multivalent Ag activates mast cells, they undergo series of
phosphorylation cascades and form IP3, which binds to the ER, resulting in a decrease in ER
Ca2+. This depletion of ER Ca2+ causes STIM1 to associate with ORAI1 and activate SOCE,
resulting in an influx of Ca2+ into the cytosol through the CRAC channel. Using previous and
current findings, we conclude that TCS-led cytosolic acidification disturbs the interaction
47

between STIM1 and ORAI1, resulting in a decreased influx of Ca2+ through the CRAC channel.
Dampened cytosolic calcium inhibits microtubule polymerization and inhibits enzyme
activation: combined together, these effects result in TCS inhibition of mast cell degranulation.
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APPENDIX A
SUPPLEMENTARY INFORMATION TO CHAPTERS 2 & 3

Section A.1. Super-Resolution Imaging. FPALM imaging was done as published previously
(Hess et al., 2006; Gudheti et al., 2013; Parent and Hess, 2019). Briefly, a 558 nm laser was
focused into the back aperture of a 60× Olympus oil objective (1.45 NA) by a 350 mm lens
(Thorlabs). The laser power out of the objective was ~9 mW. Fluorescence emission from
Dendra2 was collected by the objective and filtered through a quad band dichroic (Di01R405/488/561/635-25x36, Semrock, Rochester, NY) and 561 notch filter (NF03-561E-25,
Semrock) to remove the laser and through final emission band pass filter (558/40 nm). A
cylindrical lens of focal length 1000 mm was placed in the emission path to create astigmatism
(Huang et al., 2008). Two achromatic lenses of focal lengths +200 mm and +400 mm ware also
added in the emission path for additional magnification. Fluorescence reaching the camera
(iXon+ DU897DCS-BV, Andor Scientific, Dublin, Ireland), was recorded at a frequency of ~32
Hz with EM gain of 200. Transfected cells were chosen by observing the green (inactive) state of
Dendra2 when excited by the light from the mercury lamp filtered by a narrow excitation
bandpass filter (476/10nm, Chroma Technology, Inc., Bellows Falls, VT) and then imaged in
epi-fluorescence mode using a band pass filter (535/50 M, Chroma Technology) before viewing
through eyepieces or with the camera (EM gain disabled). After selecting a transfected cell, it
was imaged for 10000 frames. A weak intensity of 405 nm light (a few microwatts total power)
was used to illuminate the cell and photoactivate inactive Dendra2 to its active form (Gurskaya
et al., 2006).

Section A.2 Axial Position Calibration Procedure. For determination of the calibration
between the axial position and observed astigmatism, fluorescent beads were imaged with a
specific procedure. The objective was mounted on piezoelectric axial focus collar (Physik
Instrumente (PI), Karlsruhe, Germany, PD72Z1x) which controlled the axial movement of the
objective relative to the sample. Beads of diameter 0.1μm (Tetraspeck Microspheres,
Thermofisher) plated in the Nunc 8 well chamber were imaged at ten different axial positions of
the objective at a frame rate of ~32 Hz for 50 frames. The step size between each axial position
of the objective was 200 nm and was controlled by PI MicroMove software. Each PSF, whose x
and y radii are dependent on the position of the fluorophore, was fitted to localize the beads, and
determine its distance below or above the focal plane. Calibration curves were obtained by
plotting and analyzing the x and y radius as a function of axial position (Parent and Hess, 2019).
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Figure A.3. Triclosan effects on the fluorescence of Arclight-242 in RBL-2H3 mast cells
when measured through automated image analysis. Confocal image data from Figure 3.3 for
control (0 µM) and 20 µM TCS were reanalyzed and processed using automated image analysis
described in the “Automated Image Analysis” in Chapter 2. Triclosan depresses ArcLight-A242
fluorescence; these results are quantitatively similar to those obtained with the manual image
analysis method in Figure 3.3B. Values presented are means ± SEM of at least 3 independent
days of experiments per treatment. Statistically significant results, as compared to the control
(0μM TCS), are represented by ***p value< 0.001, as determined by one-way ANOVA followed
by Tukey’s post-hoc test.
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Figure A.4. Production, screening and fluorescence measurement of ArcLight-A242 RBL
stably-transfected clones.
Creation of an ArcLight-A242 stably-transfected, high-expressing, clonal RBL-2H3 mast cell
line would be useful for rapid, high-throughput studies of toxicant and drug effects on plasma
membrane potential, at various doses and timeframes. Previously, we had attempted to measure
Arclight fluorescence in transiently-transfected RBL-2H3 cells via plate reader, but the relatively
low transfection rate resulted in insufficient fluorescence signal.
Methods for (A) and (B): Production and Screening of ArcLight-A242 RBL Cell Stablytransfected Clones. RBL-2H3 mast cells were maintained and transfected with ArcLight-A242
as described in Chapter 2. Immediately following electroporation, the 100 µL cell sample was
combined with 500 µL pre-warmed, phenol red-containing RBL media, mixed gently, and placed
into a well of a sterile, tissue culture-treated 6-well plate containing 1.5 mL media for overnight
incubation at 37°C/5% CO2. The next day, cells were trypsinized, centrifuged, and reconstituted
to 1 x 106 cells/mL before serial dilution into 100 mm sterile, tissue culture-treated dishes, each
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containing 7 mL of phenol red-containing RBL media (Hutchinson et al., 2011) and a cell count
between 100 and 100,000 cells (cell number varied to optimize both cell growth and clonal
dilution; densities that gave the best results were 100 and 500 cells per well). The next day,
media was removed from each dish and was replaced with 500 µg/mL hygromycin- and phenol
red-containing RBL media. Hygromycin was used because the ArcLight-A242 construct
contains a hygromycin-resistance gene (ArcLight-A242, a gift from Vincent Pieribone; Addgene
plasmid # 36857; http://n2t.net/addgene:36857; RRID:Addgene_36857) (Jin et al., 2012) . While
a previous RBL transfection study with a different hygromycin-resistant construct employed 400
µg/mL hygromycin (Choi et al., 2009), a dose-response killing curve was conducted with
untransfected RBL cells, testing from 200 µg/ml to 1000 µg/ml, to determine the optimal
concentration (Delrue et al., 2018). While the dry hygromycin solid is stable for at least 5 years
at 2-8°C, hygromycin is stable at 37°C for 30 days when dissolved in aqueous solutions (Sigma
Aldrich), thus allowing the extended cultures needed for clonal selection. Non-toxic selective
efficiency was optimized at 500 µg/mL (data not shown). Approximately 7 to 10 days later,
separated colonies became visible. Media was discarded, 100 mm dishes were washed twice
with RBL media which was then removed. Media-dipped calcium alginate fiber-tipped wood
applicator swabs (Fisher Scientific) were used to pick individual colonies, these hygromycinresistant transfectants were plated in 12-well plates (each well containing one colony and 1.5 mL
of 500 µg/mL hygromycin- and phenol red-containing RBL media). Following a wash into fresh
hygromycin media the next day, the clones were maintained for a week. When confluent, cells
were harvested via 0.5 mL/well trypsinization, then transferred directly to 6-well plates, each
containing 2.5 mL fresh hygromycin RBL media. After a few days, the cells were harvested via
1 mL/well trypsinization, quenched with 4 mL RBL media, centrifuged, counted, and brought to
1x106 cells/mL in phenol red-free RBL media. A portion of each of these cell mixtures (100 µL)
was combined with 100 µL phenol red-free RBL media and placed into a well of an ibidi 8-well
plate and grown overnight at 37°C/5% for next-day screening (see below). The remainder of
each clone was cultured in a 37 °C and 5% CO2 incubator in a T25 flask in hygromycin- and
phenol red-containing media. The next day, ibidi wells were washed with BT and images were
taken in the presence of 200 µL BT per well. Confocal settings for ArcLight-A242 imaging are
described in Chapter 2.
Results for (A) and (B): Confocal fluorescence images of RBL-2H3 cells transiently
(A) or stably (B) expressing ArcLight-A242 show uniform localization of ArcLight at the plasma
membrane following transient transfection (A; also Fig. 3A) but irregular intracellular
distribution and aggregation of ArcLight in stably-transfected cells (B). Stable transfectants
display aggregation of the construct as well as poor localization at the plasma membrane,
compromising their viability in plasma membrane polarity assays (B).
In order to determine whether these stable transfectants possess sufficient fluorescence
signal for high-throughput plate reader experiments, Arclight fluorescence was measured in a
plate reader and compared to that of untransfected cells.
Methods For (C): Plate reader fluorescence measurements of stably-transfected ArcLightA242 RBL-2H3 mast cells. A clone of ArcLight stably-transfected cells was split into two
flasks and cultured for one week in phenol red-containing RBL media, one with and one without
500 μg/mL hygromycin. A day prior to the experiment, all media were replaced with phenol redfree media, including a flask of control untransfected RBL cells. On the day of the experiment,
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cells were harvested using cell harvest buffer (Shim et al., 2019) and plated in a Grenier 96-well
clear flat bottom plate at densities of 150,000 cells/well or 100,000 cells/well in phenol red-free
media. After a 1-h incubation at 37°C / 5% CO2, media was discarded and replaced with BT.
Fluorescence was measured at 37oC from the bottom of the wells with 485 ± 10 nm excitation
and 528 ± 10 nm emission. Gain was adjusted to 5000. Background fluorescence was subtracted,
and values for different groups were normalized to the values of non-transfected cells.
Results for (C): Whole-cell fluorescence of untransfected RBL-2H3 cells (“Plain RBL-2H3
control”) (n=42 wells) and of ArcLight stably-transfected cells grown in hygromycin (+) (n=42
wells) or without hygromycin (-) (n=21 wells) was measured (C). Values are mean ± SEM of 7
independent experiments for hygromycin-exposed transfectants and control and 4 independent
experiments for hygromycin-free transfectants. Statistical significance, represented by * p<0.05,
was determined by a one-way ANOVA followed by a Tukey’s post-hoc test. Stable
transfectants’ whole-cell fluorescence signal was not significantly different from RBL controls.
This lack of ArcLight signal can be partially explained by the result that hygromycin exposure
significantly reduces fluorescence in stable transfectants (C). Hygromycin is a protein synthesis
inhibitor (Borovinskaya et al., 2008): culturing transfectants in the presence of a protein
synthesis inhibitor may decrease expression of the protein construct.
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A)

B)

Figure A.5. Widefield images of GCaMP6-transfected Jurkat T cells. Jurkat T cells were
transfected with the GCaMP6 reporter construct and plated in fibronectin-coated ibidi plates in
phenol red-free media, as described in Chapter 2. The next day, cell media was replaced with
BT, and images were taken with a wide-field IX83 (Olympus) microscope as described in
Chapter 2. Representative fluorescence (A) and DIC (B) images indicate high transfection
efficiency of GCaMP6 in Jurkat T cells.
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APPENDIX B
DIMETHYL SULFOXIDE VEHICLE DOES NOT INTERFERE WITH GRAMICIDIN’S
INHIBITION OF PLASMA MEMBRANE POTENTIAL

Figure B.1. Effects of DMSO vehicle on gramicidin’s ability to decrease Arclight
fluorescence in RBL mast cells. A range of DMSO concentrations was assessed to determine
whether DMSO modulates gramicidin’s ability to decrease Arclight fluorescence. RBL cells
were transiently transfected with ArcLight, washed with BT, and exposed to 1 µM gramicidin
dissolved in 0.009% (N=10), 0.01% (N=9), or 0.02% (N=5) DMSO (final concentration).
Gramicidin-Arclight experiments were then performed as detailed in Chapter 2. For each
individual cell, the percentage drop in ArcLight fluorescence mean intensity incurred by 7 min
exposure to 1 µM gramicidin, in the presence of a certain DMSO concentration, was calculated,
then averaged with values from other cells under the same conditions. Gramicidin’s ability to
inhibit Arclight fluorescence is unaffected by wide range of DMSO concentrations. Data
presented are means ± SEM of at least 5 RBL cells per DMSO concentration. Analysis by oneway ANOVA followed by Tukey’s post-hoc test found no statistical significance.
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Figure B.2. Effects of DMSO vehicle on Arclight fluorescence. Since 1 µM gramicidin
treatment in figure 3.3 contained DMSO vehicle (0.003%), it was important to determine
whether 0.003% DMSO itself has any effects on ArcLight fluorescence under these experimental
conditions. RBL cells were transiently transfected with ArcLight, washed with BT, and exposed
to 0.003% DMSO (final concentration) in BT. Arclight experiments were then performed as
detailed in Chapter 2. DMSO (at 0.003%) does not interfere with Arclight fluorescence. Values
presented are means ± SEM from a single experimental day (N=6 cells). Analysis by one-way
ANOVA followed by Tukey’s post-hoc test found no statistical significance.
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APPENDIX C
SUPPLEMENTARY INFORMATION TO CHAPTER 3

Figure C.1. Effect of cellular expression level of ArcLight-A242 on TCS inhibition of
ArcLight-A242 fluorescence in human Jurkat T cells. To check whether plasmid expression
level affects the change in GEVI fluorescence in response to triclosan in human Jurkat T cells,
the initial, 0 min (pre-triclosan-exposure), background-subtracted mean fluorescence intensity of
each individual cell from Figure 3.6A’s data was analyzed. Data from Figure 3.6A, ArcLightA242 transfected cells analyzed by confocal imaging and image analysis comparing control
(0µM TCS) and 20µM TCS treatments, were plotted as individual cells’ data. The percentage
drop in ArcLight fluorescence by 15 minutes time of exposure (for control buffer-treated in A,
TCS-treated in B), for each individual cell, is plotted as a function of that particular cell’s initial
mean intensity of ArcLight. There is no correlation between plasmid expression level and the
magnitude of TCS inhibition of ArcLight fluorescence (Figure C.1B), as analyzed by linear
regression. Thus, TCS effects on GEVI fluorescence are unaffected by the “brightness” (GEVI
expression level) of the cell. Statistical results per plot are represented by equation of linear
regression and corresponding R2 values.

74

APPENDIX D

CALCIUM OSCILLATIONS IN JURKAT T CELLS

Figure D.1. Cytosolic Ca2+ levels as activated by anti-T Cell Receptor (TCR) antibody in
individual Jurkat T Cells. Jurkat cells were transiently transfected with cytosolic GCaMP6 and
exposed to 0.2 µg/ml anti-TCR OKT3 antibody. Representative live cell confocal microscopy
images (fluorescence and DIC) from a single cell immediately (A) and 4 minutes (B) after
antibody activation. Representative figures (C and D) (no error bars) show backgroundsubtracted cytosolic mean fluorescence intensity of two individual cells for 30 minutes.
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In order to investigate TCS inhibition of Ca2+ dynamics in T cells, we first visualized and
quantified Ca2+ signaling in individual, antibody-activated cells. This technique could be used in
future studies to investigate cellular Ca2+ oscillations.
Figure D.1. Visualizing and measuring Ca2+ oscillations in Jurkat T cells.
Methods for (A) and (B): First, 8-well ibidi plates were coated with 150 µL/well fibronectin
(166 µg/ml) prepared in PBS and incubated overnight in tissue culture incubator. The next day,
Jurkat T cells were transfected with pGP-CMV-GCaMP6f (a gift from Douglas Kim & GENIE
Project; Addgene # 40755; http://n2t.net/addgene:40755; RRID: Addgene_40755) (Chen et al.,
2013) using Jurkat-specific Amaxa Nucleofector transfection kit T (Lonza). The electroporated
cells were plated in phenol red-free Jurkat cell media at ~1 million cells/well in the fibronectin
pre-coated 8-well. Cells were grown for 16-24 hours at 37oC/ 5% CO2. The next day, cell media
was removed carefully with a transfer pipette to avoid cell detachment and replaced with 200 µL
BT. Right before imaging, cells were exposed to 200 µL 2x anti-TCR OKT3 monoclonal
antibody prepared in BT (final concentration of 0.2 µg/ml ) ((Holowka et al., 2018). Confocal
live cell time lapse images (collected every 6.24 seconds) were taken for 30 minutes post
addition of anti-TCR antibody in combination with BT. An Olympus FV-1000 confocal
microscope, with an Olympus IX-81 inverted microscope and a 30 milliwatt multi-argon laser
was used to collect images. GCAMP6 was imaged using a 60x oil immersion objective with NA
1.4 and 488 nm excitation, 505-605 nm band pass emission filter.
Results for (A) and (B): Fluorescence and DIC images (left and right) of a single Jurkat T cell
obtained immediately (A) and 4 minutes after (B) addition of Anti-TCR OKT3 antibody show a
sharp rise in cytosolic Ca2+ levels due to antibody activation.
To further quantify these Ca2+ levels, fluorescence images were processed using Fiji image J.
Methods for (C) and (D): In Fiji Image J (NIH), background fluorescence intensity was
subtracted from each image stack using pseudo flatfield correction. Next, by applying threshold,
binary masks of the whole cell was created. These binary masks were then further eroded to
select only the cytosol of cells. Newly-formed cytosolic binary masks were applied to transfected
cells to obtain area of the ROI, integrated density, and mean fluorescence intensity values.
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Background-subtracted mean fluorescence intensity was plotted at every 6.24 seconds (Frame 1)
up to 30 minutes (Frame 300).
Results for (C) and (D): Two representative figures depict quantified background subtracted
mean fluorescence intensity of cytosolic GCaMP6 in two individual Jurkat T cells up to 30
minutes post anti-TCR OKT3 antibody addition. These data indicate that cytosolic
Ca2+oscillations in Jurkat T cells after antibody stimulation can be captured through confocal
microscopy. Similar Ca2+ oscillations trend in RBL cells and T cells were reported in (Millard et
al., 1988; Lioudyno et al., 2008) . This technique is not high-throughput but can be potentially
used in future studies of toxicant effects on T cell Ca2+ mobilization.
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APPENDIX E
OTHER CYTOSOLIC pH INDICATORS

Figure E.1. Transfection of cytosolic pH marker pME-pHluorin2 into RBL mast cells. In
order to investigate TCS effects on cytosolic pH, RBL cells were transiently transfected with
pME-pHluorin2, which labels the cytosol and responds to pH changes with a change in its
fluorescence (Mahon, 2011). The reporter construct pME pHluorin2 was a gift from David
Raible (Addgene plasmid # 73794; http://n2t.net/addgene:73794; RRID:Addgene_73794)
(Stawicki et al., 2014). RBL cells were transfected similarly to how Lyn-tailed mCherrySEpHlourin was transfected in Chapter 2. The next day, confocal images were taken in the
presence of BT (confocal settings were similar to Arclight construct imaging as described in
Chapter 2; timepoint images were not taken in this experiment). RBL cells transfected with the
pME-pHluorin2 construct show a punctate cellular distribution, with highly uneven cytosolic
labeling. Thus, this construct may not be useful to accurately measure cytosolic pH. Another
cytosolic pH indicator known as pHRed (GW1-pHRed was a gift from Gary Yellen; Addgene
plasmid # 31473 ; http://n2t.net/addgene:31473 ; RRID:Addgene_31473) (Tantama et al., 2011),
derived from red fluorescence protein, which also reports fluorescence change in response to
changes in cytosolic pH, was available. However, pHRed does not detect any cytosolic pH
change in response to 1 µM FCCP in Neuro2Acells (Tantama et al., 2011). This result
contradicts studies that show cytosolic acidification by FCCP (Buckler and Vaughan-Jones,
1998; Berezhnov et al., 2016). Thus, we conclude that pHRed might not be a good pH indicator
to measure TCS effects.
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APPENDIX F
CYTOTOXIC EFFECTS OF CETYLPYRIDINIUM CHLORIDE IN NIH-3T3 CELLS
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Figure F.1. Cytotoxic effects of cetylpyridinium chloride (CPC) on NIH-3T3 cells.
CPC is a widely used antimicrobial product which has been effectively banned recently
from hand soaps and hand sanitizers by the FDA (Kux, 2016a; Kux, 2019), similarly to triclosan.
CPC remains in numerous consumer products, at high concentrations. Because very little is
known about CPC effects on eukaryotic cells, outside of its mitochondrial toxicity (Datta et al.,
2017), our lab has been focused on mapping the molecular mechanism by which it affects
mammalian cells. CPC cytotoxicity was tested in NIH-3T3 cells to add context to microscopy
data utilizing this cell line (to be published in a separate manuscript).
CPC (99% purity, VWR; CAS no. 123-03-5) was prepared in BT (Hutchinson et al.,
2011) by sonication (Branson 1200 ultrasonic cleaner; Branson Ultrasonics, Danbury, CT, USA)
at 150 µM and 37 °C for 20 min, protected from light. Concentrations were determined using
UV-Vis spectrophotometry (Weatherly et al., 2013) and the Beer-Lambert equation (A260
=ε260ℓc), using an ε260 of 4389 M-1 cm-1 (Bernauer, 2015).
NIH-3T3 cells were cultured as in (Weatherly et al., 2016). Cells were plated at 200,000
cells per well into each of 3 wells of a 6 well plate (Greiner) and grown overnight at 37°C/5%
CO2. Next day, cells were exposed to micromolar doses of CPC (0 µM, 5 µM, and 10 µM) and
incubated for 1 hour at 37°C/5% CO2. Cell viability were assessed using a trypan blue exclusion
assay (as in section 2.1.4). Values presented are means ± SEM of three independent experiments.
Analysis by the nonparametric Kruskal-Wallis test followed by Dunn’s post test found no
statistical significance of either CPC dose compared to control. CPC (up to 10 µM, 1 hr)
exposure does not cause cytotoxicity of NIH-3T3 cells.
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